首页> 外国专利> Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells

Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells

机译:使用自然杀伤细胞治疗急性髓细胞性白血病和多发性骨髓瘤的方法

摘要

Provided herein are methods of treating acute myeloid leukemia (AML) and multiple myeloma (MM) by administering an effective amount of a cell population comprising natural killer cells, wherein the cell population comprising natural killer cells is produced by a three- stage method comprising culturing a population of hematopoietic stem or progenitor cells in media comprising stem cell mobilizing factors, e.g., three-stage methods of producing NK cells in media comprising stem cell mobilizing factors starting with hematopoietic stem or progenitor cells from cells of the placenta, for example, from placental perfusate (e.g., human placental perfusate) or other tissues, for example, umbilical cord blood or peripheral blood. Further provided herein are methods of using the NK cells produced by the three-stage methods provided herein to suppress the proliferation of acute myeloid leukemia cells. In certain embodiments, the NK cells produced by the three-stage methods described herein are used in combination with IL- 2.
机译:本文提供了通过施用有效量的包含天然杀伤细胞的细胞群来治疗急性髓细胞性白血病(AML)和多发性骨髓瘤(MM)的方法,其中包含天然杀伤细胞的细胞群是通过包括培养在内的三阶段方法产生的包含干细胞动员因子的培养基中的造血干细胞或祖细胞群,例如,在包含以胎盘细胞为基础的造血干细胞或祖细胞开始的干细胞动员因子的培养基中生产NK细胞的三阶段方法胎盘灌注液(例如人胎盘灌注液)或其他组织,例如脐带血或外周血。本文还提供了使用通过本文提供的三阶段方法产生的NK细胞抑制急性髓性白血病细胞增殖的方法。在某些实施方案中,通过本文所述的三阶段方法产生的NK细胞与IL-2组合使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号